Overview of the Funding Round
Honest Health has secured a landmark $140 million capital raise, marking a major milestone in the shift toward value-based care across U.S. health systems. NewSpring Healthcare, a sector-focused strategy within NewSpring Capital, led the investment. The raise signals strong market confidence in Honest Health’s model. It also reflects the growing urgency for scalable, clinician-led solutions that help health systems succeed under risk-based payment frameworks.
What Honest Health Does
Honest Health is a physician-led, value-based care enablement organization. It partners with health systems and providers to improve patient outcomes while reducing overall costs. Specifically, the company achieves this through three core pillars:
- Technology-enabled care coordination
- Quality improvement programs
- Actionable clinical and operational insights
Together, these capabilities help health systems manage risk more effectively. Moreover, Honest Health gives providers the tools and accountability structures needed to transition from volume-based to value-based care models. This transition, while challenging, is critical to the long-term sustainability of healthcare delivery in the United States.
NewSpring Healthcare’s Role
A Strategic, Sector-Focused Partner
NewSpring Healthcare brings deep sector-specific expertise and executive operating experience to this partnership. The team works directly with founders and CEOs to navigate periods of accelerated growth. They also help portfolio companies identify key inflection points and make critical financial and operational decisions with confidence.
Mike Kaplan, NewSpring Partner and board member of Honest Health, captured the opportunity well: “Value-based care continues to reshape the healthcare landscape, creating significant demand for partners that can support execution at scale. Honest Health has demonstrated a strong ability to help health systems navigate this transition, and we see substantial opportunity to expand the company’s reach.”
NewSpring Capital has over $3.5 billion in assets under management and more than 250 investments completed across sectors including healthcare, technology, and business services. For more than 25 years, the firm has focused on the lower-middle market, supporting sustainable growth for founders and management teams.
Key Investors and Syndicate
Strong Institutional Backing
The $140 million raise draws participation from a robust syndicate of investors. Beyond NewSpring Healthcare as lead, the round includes support from:
- K2 HealthVentures
- Rubicon Founders
- Oak HC/FT
- Welsh, Carson, Anderson & Stowe (WCAS)
- Durable Capital Partners
This diverse group of institutional investors reflects widespread confidence in Honest Health’s strategy, market positioning, and management team. Each investor brings complementary expertise in healthcare services, venture capital, and growth equity. Consequently, Honest Health enters its next phase of growth with both capital and deep advisory resources behind it.
Leadership Behind the Vision
Experienced Operators with Proven Track Records
Rob Bessler, M.D., serves as CEO of Honest Health. He is a physician leader and entrepreneur who previously founded Sound Physicians and grew it into a multibillion-dollar organization operating across 42 states. His blend of clinical and executive experience gives Honest Health a rare perspective on the challenges providers face.
Honest Health was founded in 2021 by Adam Boehler, Abe Sutton, and Matt Kim of Rubicon Founders. Importantly, Adam Boehler previously served as director of the Center for Medicare and Medicaid Innovation (CMMI). Currently, Abe Sutton leads that same role — a connection that gives Honest Health unparalleled insight into federal value-based care policy.
Matt Kim, partner at Rubicon Founders, reflected on the journey: “Honest Health was created with the conviction that real transformation in healthcare only happens when providers have the tools, accountability and support to focus on value over volume. In a short period of time, the company has demonstrated that belief in action, delivering measurable improvements in patient outcomes.
How the Funds Will Be Used
Investing in Growth and Expansion
Honest Health plans to deploy the new capital across several strategic priorities. First, the company will expand into new geographic markets. Second, it will deepen partnerships with health systems, provider organizations, and payers. Third, proceeds will support the buildout of scalable infrastructure to support more complex risk arrangements.
As Dr. Bessler noted: “Health systems and providers face growing demands to improve outcomes and manage costs, accelerating the need for value-based care models anchored in strong clinical leadership, proven processes, and scalable infrastructure.”
Additionally, Leerink Partners served as exclusive financial advisor. Ropes & Gray provided legal counsel to Honest Health in connection with the transaction.
Why This Investment Matters
A Critical Turning Point for Value-Based Care
Value-based care adoption is no longer optional — it is essential. Health systems across the country face mounting pressure from payers and regulators to demonstrate measurable improvements in quality and cost efficiency. Furthermore, the transition from fee-for-service to risk-based models requires significant operational, technological, and clinical change management.
Honest Health addresses precisely this challenge. By combining physician leadership, proven processes, and technology-enabled insights, the company helps providers move through this transformation with confidence. The $140 million raise positions Honest Health to broaden its national footprint and deliver measurable performance for health systems navigating increasingly complex risk environments.
Therefore, this investment is not just a financial milestone. It is a strong signal that value-based care enablement is a top priority for institutional capital — and that Honest Health leads that space.
